The inhibition of apoptosis in myositis and in normal muscle cells

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5459-5465

  Nagaraju, Kanneboyina ^a,c   Casciola Rosen, Livia ^c   Rosen, Antony ^c   Thompson, Cynthia ^d   Loeffler, Lisa ^a   Parker, Tomasina ^a   Canning, Carol ^a   Rochon, Paul J ^a   Gillespie, John ^b   Plotz, Paul ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INHIBITOR PROTEIN;

APOPTOSIS; ARTICLE; CASE REPORT; CELL PROTECTION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MUSCLE BIOPSY; MYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0034658072     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5459     Document Type: Article

References (31)

1. Tews, D. S., and H. H. Goebel. 1997. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies, Neuropathol Appl. Neurobiol. 23:331.
2. Tews, D. S., and H. H. Goebel. 1996. DNA fragmentation and BCL-2 expression in infantile spinal muscular atrophy. Neuromitscul. Disord. 6:265.
3. Schneider, C., R. Gold, M. C. Dalakas, M. Schmied, H. Lassmann, K. V. Toyka, and H. P. Hartung. 1996. MHC class 1-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J. Neuropathol. Exp. Neurol. 55:1205.
4. Olive, M., J. A. Martinez-Matos, J. Montero, and I. Ferrer. 1997. Apoptosis is not the mechanism of cell death of muscle fibers in human muscular dystrophies and inflammatory myopathies. Muscle Nerve 20:1328.
5. Inukai, A., Y. Kobayashi, K. Ito, M. Doyu, A. Takano, H. Honda, and G. Sobue. 1997. Expression of Fas antigen is not associated with apoplosis in human myopathies. Muscle Nerve 20:702.
6. Behrens, L., A. Bender, M. A. Johnson, and R. Hohlfeld. 1997 Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 120:929.
7. Tews, D. S., and H. H. Goebel. 1998. Cell death and oxidative damage in inflammatory myopathies. Clin. Immumol. Immunopathol. 87:240.
8. Engel, A. G., R. Hohlfeld, and B. Q. Banker. 1994. The polymyositis and dermatomyositis syndromes. In Myology. A. G. Engel and C. Franzini-Armstrong, eds. McGraw-Hill, New York, p. 1335.
9. Arahata, K., and A. G. Engel. 1986. Monoclonal antibody analysis of mononuclear cells in myopathies. III. Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann. Neurol. 19:112.
10. Karpati, G., Y. Pouliot, and S. Carpenter. 1988. Expression of immunoreactive major histocompatibilily complex products in human skeletal muscles. Ann. Neurol. 23:64.
11. Emslie-Smith, A. M., K. Arahata, and A. G, Engel. 1989. Major histocompatibility complex class 1 antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20:224.
12. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, and T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10:581.
13. Klas, C. K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
14. Rothstein, T. L., J. K. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163.
15. Cherin, P., S. Herson, M. C. Crevon, J. J. Hauw, P. Cervera, P. Galanaud, and D. Emilie. 1996. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J. Rheumatol. 23:1135.
16. Goebels, N., D. Michaelis, M. Engclhardt, S. Huber, A. Bender, D. Pongratz, M. Johnson, H. Wekerle, J. Tschopp, D. Jenne, and R. Hohlfeld. 1996. Differential expression of perforin in muscle-intiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97:2905.
17. Nagaraju, K., N. Raben, G. Merritt, L. Loeffler, K. Kirk, and P. Plotz. 1998. A variety of cylokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proindammatory stimuli. Clin. Exp. Immunol. 113:407.
18. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
19. Poluha, W., D. K. Poluha, B. Chang, N. E. Crosbie, C. M. Schonhoff, D. L. Kilpatrick, and A. H. Ross. 1996. The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1335.
20. Perlman, H., L. J. Pagliari, C. Georganas, T. Mano, K. Walsh, and R. M. Pope. 1999. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-medialed apoptosis. J. Exp. Med. 190: 1679.
21. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123.
22. Kuwano, K., N. Hagimoto, M. Kawasaki, T. Yatomi, N. Nakamura, S. Nagata, T. Suda, R. Kunitake, T. Maeyama, H. Miyazaki, and N. Hara. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104: 13.
23. Strasser, A., A. W. Harris, D. C Huang, P. H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136.
24. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386.
25. Hu, S., C. Vincenz, M. Buller, and V. M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis J. Biol. Chem. 272:9621.
26. Bertin, J., R. C. Armstrong. S Ottilie, D. A. Martin, Y. Wang, S. Banks, O. H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 14:1172.
27. Shu, H. B., D. R. Halpin, and D. V. Goeddel. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751.
28. Rasper, D. M., J. P. Vaillancourt, S. Hadano, V. M. Houtzager, I. Seiden, S. L. Keen, P. Tawa, S. Xanthoudakis, J. Nasir, D. Martridale, et al. 1998. Cell death attenuation by "Usurpin," a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:271.
29. Srinivasula, S. M., M. Ahmad, S. Ottilie, F. Bullrich, S. Banks, Y. Wang, T. Fernandes-Alnemri, C. M. Croce, G. Litwack, K. J. Tomaselli, et al. 1997. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/ TNFR1-induced apoptosis. J. Biol. Chem. 272:18542.
30. Inohara, N., L. del Peso, T. Koseki, S. Chen, and G. Nunez. 1998. RICK. a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. [Published erratum appears in 1998. J. Biol. Chem. 273:18675.] J. Biol. Chem. 273:12296.
31. Kataoka, T., M. Schroter, M. Hahne, P. Schneider, M. Irmler, M. Thome, C. J. Froelich, and J. Tschopp. 1998. FLIP prevents apoplosis induced by death receptors hut not by perforin/granzyme B. chemotherapeutic drugs, and γ irradiation. J. Immunol. 161:3936.